PHAR vs IOVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

PHAR

39.1
AI Score
VS
PHAR Wins

IOVA

35.7
AI Score

Investment Advisor Scores

PHAR

39score
Recommendation
AVOID NEW MONEY

IOVA

36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR IOVA Winner
Forward P/E 212.766 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -3.2% 65.7% IOVA
Earnings Growth -62.9% 0.0% IOVA
Tradestie Score 39.1/100 35.7/100 PHAR
Profit Margin 2.5% -89.1% PHAR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED IOVA

Relative Price Performance (Last 90 Days)

PHAR 1M: -12.9% · 3M: -31.9% IOVA 1M: +64.9% · 3M: +239.3%

Current Technical Phase

PHAR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 34

RSI (14): 33.8 · Price: $9.75

IOVA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (42.5% over 20 days), RSI 80

RSI (14): 79.8 · Price: $14.22

Fundamentals Snapshot

Metric PHAR IOVA
Market Cap — —
Forward P/E 31.8 -60.0
Trailing P/E 71.1 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin 0.9% 0.5%
Operating Margin 0.0% -0.5%
EPS 0.14 -0.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PHAR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.